Skip to main content

Nonprofit · EIN 20-0811343

KAREN WYCKOFF REIN IN SARCOMA

Tax-exempt · FRIDLEY, MN 55432

Financials

$606K$554K2023$577K$697K2024
Revenue Expenses · by fiscal year end
Financials of KAREN WYCKOFF REIN IN SARCOMA by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$577,435$697,342-$119,907$1,093,636$55,531$1,038,105
December 31, 2023990$606,354$554,483$51,871$1,175,955$15,280$1,160,675
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$539,554
Program service revenue
$5,000
Investment income
$18,940
Net gain from sales of assets
$7,737
Net income from fundraising events
$11,072
Net income from gaming
$2,385
Net income from sales of inventory
$484
Other revenue
$13,941

Expenses

Grants and similar amounts paid
$209,783
Compensation of officers, directors and key employees
$121,105
Other salaries and wages
$228,672
Salaries, compensation and benefits (total)
$393,671
Professional fundraising fees
$0
Accounting fees
$4,862
Occupancy
$5,700
Travel
$5,373
Program services (functional)
$381,571
Management and general (functional)
$177,512
Fundraising (functional)
$138,259

Balance sheet and other

Total assets, start of year
$1,175,955
Total assets, end of year
$1,093,636
Total liabilities, end of year
$55,531
Net assets, end of year
$1,038,105
Publicly traded securities
$548,997
Net assets without donor restrictions
$508,608
Net assets with donor restrictions
$529,497
Gross receipts
$1,487,574
Employees
4
Volunteers
117
Year formed
2004
State of legal domicile
MN

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Lachelle SemankoExecutive Director
Officer
40$115,385$5,720
Scott Okuno MDBoard Member
Trustee or director
1$0$0
Colin RyanBoard Member
Trustee or director
1$0$0
Maureen Anderson DNPBoard Member
Trustee or director
1$0$0
Laura GagneBoard Member
Trustee or director
1$0$0
Jason PatalonisBoard Member
Trustee or director
1$0$0
Brendan DillonBoard Member
Trustee or director
1$0$0
Stephanie Terezakis MDBoard Member
Trustee or director
1$0$0
Andrea Espejo Freire MDBoard Member
Trustee or director
1$0$0
John Charlson MDBoard Member
Trustee or director
1$0$0
Dr David LargaespadaBoard Member
Trustee or director
1$0$0
Blake HastingsBoard Member
Trustee or director
1$0$0
Eric LienPresident
Trustee or director, Officer
2$0$0
Conner O'BrienVice President
Trustee or director, Officer
2$0$0
Mitch AthertonTreasurer
Trustee or director, Officer
1$0$0
1 more people on this return
NameTitleHours / weekCompensation
Aaron HalbeSecretary
Trustee or director, Officer
1$0
990 for the year ended December 31, 2023: 18 people
NameTitleHours / weekCompensation
Lachelle SemankoExecutive Director
Officer
40$83,387
Janelle CalhounExecutive Director
Officer
40$31,375
Scott Okuno MDBoard Member
Trustee or director
1$0
Colin RyanBoard Member
Trustee or director
1$0
Maureen Anderson DNPBoard Member
Trustee or director
1$0
Laura GagneBoard Member
Trustee or director
1$0
Jason PatalonisBoard Member
Trustee or director
1$0
Brendan DillonBoard Member
Trustee or director
1$0
Stephanie Terezakis MDBoard Member
Trustee or director
1$0
Andrea Espejo Freire MDBoard Member
Trustee or director
1$0
Valerie Lopez TorresBoard Member
Trustee or director
1$0
John Charlson MDBoard Member
Trustee or director
1$0
Dr David LargaespadaBoard Member
Trustee or director
1$0
Blake HastingsBoard Member
Trustee or director
1$0
Eric LienPresident
Trustee or director, Officer
2$0
Conner O'BrienVice President
Trustee or director, Officer
2$0
Mitch AthertonTreasurer
Trustee or director, Officer
1$0
Aaron HalbeSecretary
Trustee or director, Officer
1$0

Address and contacts

Address (IRS master file)
7401 CENTRAL AVE NE STE 1, FRIDLEY, MN 55432-3572
In care of
% JANELLE CALHOUN
Principal officer (990 for 2024)
Mitch Atherton, 7401 Central Avenue NE A, Fridley, MN 55432
Signed the 990
Lachelle Semanko, Executive Director
Phone
(763) 205-1467
Return prepared by
BWK Rogers PC

Mission

Our three-pronged mission: educating the public and medical community about sarcomas, supporting sarcoma patients and their loved ones, and funding research directed toward developing new treatments and finding a cure for sarcoma cancers.

990 for the year ended December 31, 2024

Program accomplishments

  • Rein in Sarcoma (RIS) was started in 2001 by Karen Wyckoff, a 25-year-old Synovial Sarcoma patient. As she fought this rare cancer, she thought there were things that needed doing to increase the quality of life and odds of survival for all sarcoma patients. As she started the organization, she developed the mission as it still remains today: We are dedicated to educating the public and medical community about sarcoma, supporting sarcoma patients and their loved ones, and funding research directed toward developing new treatments and finding a cure for sarcoma cancer. Research for Sarcoma Cancer: RIS has partnered with many top-notch research institutions including: University of Minnesota, Mayo Clinic, Children's Minnesota, University of Calgary, Case Western Reserve, University of Michigan, and Aveni Foundation. RIS has funded seed money of more than $2.5M in high impact and collaborative research, which has generated more than $13M in additional support. Ninety-one research funding awards have been made to date. Education: RIS has established and expanded its Sarcoma Scholar Program to educate Medical Students and Advanced Practice students about sarcoma. This program began in 2009 with 2 scholars participating from the University of Minnesota and has now grown to 16 scholars from across the country in 2024, participating from University of Minnesota, Mayo Clinic Alix School of Medicine, University of Florida, University of Michigan, University of Iowa, Winona State University, Medical School of Wisconsin, and University of Wisconsin-Madison. Scholars educate their peers and public about sarcoma, complete sarcoma related projects, and go through a year-long sarcoma education program offered by RIS and sarcoma experts, specialists, and mentors. In addition, RIS provides free Patient Education Sarcoma Guidebooks to newly diagnosed patients and their caregivers. Guidebooks are also sent to sarcoma centers across the nation for distribution and are available for free download on the RIS website. The 9th Edition Guidebook was completed in 2024. Other educational activities include RIS participation in annual sarcoma related conferences, presenting and tabling opportunities to increase education. RIS has a YouTube channel that houses patient stories and educational videos. Patient and Family Support: Each year, RIS holds a Party in the Park event which is free to sarcoma patients, family members and those who have lost a loved one to sarcoma. Other patient and family support activities include peer to peer mentorship from other sarcoma survivors, Tote Bags of Hope filled with items for newly diagnosed and/or hospitalized patients, an active social media group for sarcoma patients and loved ones, Microgrants for patients in need of financial support during treatment and an in person monthly support group. Rein in Sarcoma is the largest and most well-known sarcoma foundation in the Midwest and continues to expand their services and reach nationwide.
    Expenses $381,571 · grants $209,783 · revenue $5,484

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
20-0811343
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2004
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$1,093,636
Income (IRS master file)
$1,487,574

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$577,435$697,342$1,093,636XML
990December 2023$606,354$554,483$1,175,955XML
990December 2022$716,594$736,754$1,199,056IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-0811343).

Questions about KAREN WYCKOFF REIN IN SARCOMA

What is the EIN of KAREN WYCKOFF REIN IN SARCOMA?
The employer identification number (EIN) of KAREN WYCKOFF REIN IN SARCOMA is 20-0811343.
Is KAREN WYCKOFF REIN IN SARCOMA tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2004.
Are donations to KAREN WYCKOFF REIN IN SARCOMA tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does KAREN WYCKOFF REIN IN SARCOMA file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of KAREN WYCKOFF REIN IN SARCOMA due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did KAREN WYCKOFF REIN IN SARCOMA last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of KAREN WYCKOFF REIN IN SARCOMA?
The 990 for the year ended December 31, 2024 names Mitch Atherton.
Who are the officers and directors of KAREN WYCKOFF REIN IN SARCOMA?
The 990 for the year ended December 31, 2024 lists 16 people; 1 received compensation from the organization, the highest $115,385 (Lachelle Semanko, Executive Director).
How much revenue does KAREN WYCKOFF REIN IN SARCOMA have?
On its 990 for the year ended December 31, 2024 it reported revenue of $577,435, expenses of $697,342 and total assets of $1,093,636 at year end.

Other nonprofits in FRIDLEY

All nonprofits in FRIDLEY · Minnesota · Medical research